BioLASCO Taiwan Co., Ltd. (6662.TWO)

TWD 34.3

(-1.44%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Revenue 264.72 Million 235.91 Million 227.58 Million 298.87 Million 346.68 Million
Cost of Revenue 160.37 Million 131.42 Million 122.47 Million 168.58 Million 220.85 Million
Gross Profit 104.35 Million 104.48 Million 105.1 Million 130.29 Million 125.83 Million
Operating Expenses 104.35 Million 55.21 Million 51.17 Million 52.73 Million 54.95 Million
Selling, General and Administrative Expenses 53.54 Million 55.21 Million 51.17 Million 52.73 Million 54.95 Million
Research and Development Expenses - - - - -
Other Expenses - -464 Thousand 236 Thousand 508 Thousand -
Cost and Expenses 213.91 Million 186.64 Million 173.65 Million 221.32 Million 275.8 Million
Operating Income 63.33 Million 54.22 Million 57.35 Million 79.26 Million 70.87 Million
Interest Expense 1.29 Million 1.08 Million 877 Thousand 768 Thousand 251 Thousand
Income Tax Expense 12.24 Million 10.82 Million 11.28 Million 15.7 Million 13.74 Million
Earnings before Tax 61.99 Million 53.13 Million 56.44 Million 78.5 Million 68.71 Million
Net Income 49.74 Million 42.31 Million 45.15 Million 62.8 Million 54.97 Million
Earnings Per Share Basic 1.94 1.65 1.76 2.45 2.19
Earnings Per Share Diluted 1.94 1.65 1.76 2.45 2.19
Weighted Average Shares Outstanding 25.61 Million 25.61 Million 25.61 Million 25.61 Million 25.1 Million
Weighted Average Shares Outstanding (Diluted) 25.65 Million 25.61 Million 25.66 Million 25.66 Million 25.14 Million
Gross Margin 0.39 0.44 0.46 0.44 0.36
EBIT Margin 0.28 0.27 0.30 0.30 0.23
Profit Margin 0.19 0.18 0.20 0.21 0.16
EBITDA 73.9 Million 59.5 Million 67.34 Million 88.22 Million 78.1 Million
Earnings Before Tax Margin 0.24 0.23 0.25 0.27 0.20

Income Statement Charts